Swiss stocks - Factors to watch on December 17

2 minute read
Register now for FREE unlimited access to Reuters.com

ZURICH/BERLIN, Dec 17 (Reuters) - The Swiss blue-chip SMI (.SSMI) was seen opening 0.44% lower at 12,735 points on Friday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:

CREDIT SUISSE (CSGN.S)

Register now for FREE unlimited access to Reuters.com

Eric Varvel, chairman of Credit Suisse's investment bank, is in discussions to leave the company, the Financial Times reported on Thursday, citing people briefed on the matter. read more

UBS (UBSG.S)

UBS is leaning toward appealing to France's top court in tax case- Bloomberg News

COMPANY STATEMENTS

* VAT Group (VACN.S) said it would invest 160 million Swiss francs to increase capacities in Malaysia and Switzerand and build a new Swiss site. VACN.S

* Baloise Holding (BALN.S) said it would nominate two women, Claudia Dill and Maya Bundt, to join its board as two male directors decide to step down at the next AGM. BALN.S

* Basilea (BSLN.S) said it received FDA approval on its Investigational New Drug application for oncology drug candidate BAL0891. BSLN.S

* Hochdorf said it was selling a site to Hochdorf Municipality. HOCN.S

* Addex Therapeutics (ADXN.S) said it raised $10.0 million in equity financing. ADXN.S

ANALYSTS' VIEWS

MEYER BURGER TECHNOLOGY AG (MBTN.S): CREDIT SUISSE CUTS TARGET PRICE TO CHF 0.28 FROM CHF 0.30

VIFOR PHARMA AG (VIFN.S): CFRA RAISES TARGET PRICE TO CHF 167 FROM CHF 130

STRAUMANN HOLDING AG (STMN.S): DEUTSCHE BANK RAISES TARGET PRICE TO CHF 2300 FROM CHF 2260

ECONOMY

No major Swiss economic data scheduled.

Register now for FREE unlimited access to Reuters.com
Reporting by Zurich newsroom and Berlin Speed Desk

Our Standards: The Thomson Reuters Trust Principles.